Fresenius Medical Care U.S. Finance (FMC) has raised a total of $650 million in a sale of senior notes, Reuters reports. The size of the deal was increased from an initially planned $500 million. The bonds of the dialysis products provider, which carry a coupon rate of 5.75%, will mature on Feb. 15, 2021. The joint book-running managers for the sale were Bank of America Merrill Lynch, Deutsche Bank, Barclays and JP Morgan.

Click here for the story from Reuters.